AddLife AB engages in the ownership and acquisition of firms in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm and currently employs 2,295 full-time employees. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Accelleron Industries AG 주요 수익원은 Medium & Low Speed Products and Services이며, 최신 수익 발표에서 수익은 771,985,126입니다. 지역별로는 Europe이 Accelleron Industries AG의 주요 시장이며, 수익은 335,852,787입니다.
AddLife AB (publ)은 수익성이 있나요?
no, 최신 재무제표에 따르면 Accelleron Industries AG의 순손실은 $0입니다.